1. Product Overview
2.
Research Methodology
3.
Impact of COVID-19 on Vietnam Over the counter (OTC)
drugs (OTC) Drugs Market
4. Executive Summary
5. Voice of Customers
6. Vietnam Over the
counter (OTC) drugs (OTC) Drugs Market Outlook
6.1.
Market Size & Forecast
6.1.1. By Value
6.2.
Market Share & Forecast
6.2.1. By Product (Cough,
Cold and Flu; Vitamins, Mineral, and Supplements (VMS); Analgesics;
Gastrointestinal Products; Dermatology Products; Others)
6.2.2. By Route of
Administration (Oral, Topical, Parenteral)
6.2.3. By Dosage Form
(Tablets, Capsules, Liquids & Solution, Creams/Lotions/Ointments, Others)
6.2.4. By Distribution
Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)
6.2.5. By Region
6.2.6. By Company (2021)
6.3. Product Market Map
7. Vietnam Cough, Cold
and Flu Over the counter (OTC) drugs (OTC) Drugs Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value
7.2.
Market Share & Forecast
7.2.1. By Route of Administration
7.2.2. By Dosage Form
7.2.3. By Distribution
Channel
8. Vietnam Vitamins,
Mineral and Supplements (VMS) Over the counter (OTC) drugs (OTC) Drugs Market
Outlook
8.1.
Market Size & Forecast
8.1.1. By Value
8.2.
Market Share & Forecast
8.2.1. By Route of
Administration
8.2.2. By Dosage Form
8.2.3. By Distribution
Channel
9. Vietnam Analgesics Over
the counter (OTC) drugs (OTC) Drugs Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value
9.2.
Market Share & Forecast
9.2.1. By Route of
Administration
9.2.2. By Dosage Form
9.2.3. By Distribution
Channel
10. Vietnam
Gastrointestinal Over the counter (OTC) drugs (OTC) Drugs Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Route of
Administration
10.2.2. By Dosage Form
10.2.3. By Distribution
Channel
11. Vietnam Dermatology Over
the counter (OTC) drugs (OTC) Drugs Market Outlook
11.1.
Market Size & Forecast
11.1.1. By Value
11.2.
Market Share & Forecast
11.2.1. By Route of
Administration
11.2.2. By Dosage Form
11.2.3. By Distribution
Channel
12. Market Dynamics
12.1.
Drivers
12.2.
Challenges
13. Market Trends &
Developments
14. Policy &
Regulatory Landscape
15. Vietnam Economic
Profile
16. Competitive
Landscape
16.1.
Competition Outlook
16.2.
Company Profiles
16.2.1. Sanofi-Aventis
Vietnam Company
16.2.2. GlaxoSmithKline
Vietnam
16.2.3. Reckitt Benckiser
Vietnam
16.2.4. Imexpharm
Pharmaceutical Joint Stock Company
16.2.5. DHG Pharmaceutical Joint Stock Company
16.2.6. Traphaco Joint Stock
Company
16.2.7. Binh Dinh
Pharmaceutical and Medical Equipment Joint Stock Company
16.2.8. Vimedimex
Medi-Pharma Joint Stock Company
16.2.9. Vietnam
Pharmaceutical Corporation
16.2.10.
Ha Tay Pharmaceutical Joint Stock Company
Strategic
Recommendations